From: Differences in Achilles tendon stiffness in people with gout: a pilot study
 | Gout (n = 24) | Non-gout (n = 26) |
---|---|---|
Male/Female (n) | 19/5 | 21/5 |
Mean age (SD) | 70.63 (11) | 72.73 (10) |
Mean BMI (SD)* | 30.53 (4.97) | 26.98 (4.77) |
Ethnicity | ||
 Caucasian | 23 (96%) | 25 (96%) |
 Non-Caucasian | 1 (4%) | 1 (4%) |
 Mean self-reported relative physical activity (range 1–3) | 1.86 | 1.88 |
Comorbidities N (%) | ||
 Diabetes | 12 (50) | 11 (42) |
 Hypertension | 18 (75) | 15 (58) |
 Dyslipidaemia | 15 (63) | 13 (50) |
 Cardiac disease | 10 (42) | 6 (23) |
 Chronic kidney disease | 8 (33) | 2 (6) |
Mean duration gout (SD) | 9.39 (8.49) years | – |
Pharmacological management gout | – | |
 None | 7 (29) |  |
 NSAIDs | 2 (8) |  |
 Prednisolone | 2 (8) |  |
 Allopurinol | 10 (42) |  |
 Colchine | 3 (13) |  |